BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 3, 2004
View Archived Issues
Prognosis and predictors for survival in Alzheimer's disease after initial diagnosis
Read More
Benefits of zinc supplementation in the treatment of attention deficit hyperactivity disorder
Read More
S-3304 reported to inhibit MMP activity in advanced cancer
Read More
Good safety and pharmacokinetic profile of AMD-070 in healthy volunteers
Read More
Long-term effects of everolimus on allograft vascularity after cardiac transplantation
Read More
Melatonin reported to delay allograft rejection in a cardiac transplant model
Read More
Chemokine receptor CCR7 implicated in transplant arteriosclerosis
Read More
PKC-412 improves retinal volume and visual acuity in DME patients
Read More
Rasagiline reported to delay functional decline in early PD
Read More
Alpha lipoic acid reported to inhibit MMP-9 in MS patients
Read More
Eszopiclone improves next day function of elderly patients with chronic insomnia
Read More
Promising topical ciclosporin prodrug against corneal graft rejection
Read More
Zonisamide induces resolution of RLS symptoms
Read More
Affimed presents anti-CD3 antibodies and their use in transplant rejection therapy
Read More
Aventis patent covers new quinoline-based antibacterial agents
Read More
Gruenenthal presents novel 5-HT reuptake inhibitors for pain, depression, etc.
Read More
Two series of HNE inhibitors and their use claimed by Bayer scientists
Read More
Boehringer Ingelheim patent covers MCH antagonists for obesity and other uses
Read More
New efflux pump inhibitors under investigation at Essential Therapeutics
Read More
Incara's catalytic antioxidant, AEOL-10150, prolongs survival in ALS mice
Read More
Biovitrum licenses project in metabolic diseases
Read More
CRADA covers evaluation of CEL-1000 with new adjuvants against malaria
Read More
Primary endpoints met in FluBlOk phase IIb trial
Read More
Cubist discontinues OCTX development program
Read More
OrthoLogic to acquire Chrysalis BioTechnology
Read More
Phase II TroVax trial cleared to commence for metastatic renal cancer
Read More
Polyphenon E Ointment enters phase II trial for actinic keratosis
Read More
Interim results for Theralux in NHL
Read More
ATI-7505 enters clinic
Read More
Jerini extends Baxter collaboration
Read More
Point's boroproline compound shows peptide adjuvant activity
Read More
SBIR supports development of gp41 inhibitors at Locus
Read More
Latest Rapinex NDA filing accepted for review
Read More